Lumibird enters into exclusive negociations for the sale of its medical division to IPG Photonics Corporation

July 16, 2026

A defining milestone in Lumibird’s development, creating two focused leaders for the next stage of their growth.

Following receipt of a binding offer, Lumibird Group announces today that it has entered into exclusive negotiations for the sale of its Medical Division to IPG Photonics Corporation, for an enterprise value of €300 million, which may be increased by an earn-out of up to €50 million based on future performance in 2026 and 2027.

More than a portfolio transaction, this proposed transaction would represent a defining milestone in Lumibird’s history.

👉 Read our press release: : https://www.lumibird.com/wp-content/uploads/260716_LUMIBIRD_MEDICAL_EN.pdf